The company was established in February 2017, with its headquarters located in Xiangtan City, Hunan Province. The first phase covers an area of 92 acres with a total investment of 200 million RMB. The company's main business includes the research, development, production, and sales of specialty APIs (Active Pharmaceutical Ingredients) and pharmaceutical intermediates, as well as providing customers with custom processing and R&D services. The products are characterized by high R&D difficulty, significant technical barriers, and unique production processes.

We are capable of providing various special products to customers with strong R&D capabilities; we can supply products ranging from gram to kilogram and even ton quantities; and we can conduct reactions from -100°C to 300°C. R&D strength is the core competitiveness of the company, which maintains high annual investment in R&D. Additionally, the company has an R&D center in Shanghai and maintains strong collaborative R&D relationships with numerous universities and research institutes.

Our specialty lies in rapidly converting R&D achievements into industrial production within specified timeframes according to requirements. Currently, we primarily provide services in areas such as liver disease, cardiovascular and cerebrovascular, respiratory systems, high-end fluorine products, and custom processing for customers.

Our goal is to achieve integrated upgrading from "pharmaceutical intermediates to APIs to formulations," realizing the vision of "serving health and building brands." We not only provide customers with the best pharmaceutical chemical products but also create value for our clients.

Integrity and win-win cooperation are our fundamental strategic principles.